Biolab expands the Trifor family and introduces Trifor Turmeric in the joint health category

Biolab Farmacêutica is expanding its Trifor line with the launch of Trifor Turmeric, its new offering for the joint health supplement market. This new product enriches the brand’s portfolio, which already includes sachet and capsule versions, offering comprehensive and versatile options for joint health.

This expansion reflects a striking reality in the country: more than 15 million Brazilians live with joint wear and tear. The impact is even more evident among older adults and women: about 73% of cases occur in people over the age of 55, and 60% affect women, which drives the search for practical solutions for self-care and prevention in everyday life.

Available in coated tablets that are gluten-free, lactose-free, and sugar-free, Trifor Turmeric features a unique formulation that combines 130 mg of curcumin, 40 mg of type II collagen, 150 mg of hyaluronic acid, and 750 mg of glucosamine. Trifor Turmeric contains type II collagen, which helps maintain joint function.

For the pharmaceutical retail sector, the product is set to strengthen the brand’s presence on store shelves and meet the growing demand for products in this category. The product reinforces Biolab’s commitment to the future of preventive health, ensuring autonomy and freedom of movement at every stage of life.

You can also read the article via the link: Biolab expands the Trifor family and introduces Trifor Turmeric in the joint health category